Early studies reported that PGAM5 is markedly elevated in response to cardiac stress resulting from myocardial ischemia–reperfusion injury [12], chronic doxorubicin exposure [13], and lipopolysaccharide exposure [14]. This evidence concerns the gene PGAM5 and myocardial ischemia.